Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...

Rendon Labador confirmed his removal as a coach from the Philippine National Police’s weight reduction program. “Hindi po ako ...

Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal ...

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

A city councillor has floated the idea of reducing fees at the fitness and weight room at a city pool. *Special offer only ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

Amgen's MariTide showed strong weight loss and metabolic gains in Phase 2, with no new safety signals as Phase 3 trials begin in obesity and T2D.

The effect of Novo Nordisk’s amycretin injections on body weight showed no signs of plateauing after 36 weeks, suggesting the ...

Novo Nordisk's experimental drug amycretin shows promising results in early trials, aiding significant weight loss in ...

For the majority of people who lose weight, keeping the weight off can be challenging. Research has shown biological, behavioral, and environmental factors may undermine weight-loss maintenance.